<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137857">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01899781</url>
  </required_header>
  <id_info>
    <org_study_id>EMC-003812-CTIL</org_study_id>
    <nct_id>NCT01899781</nct_id>
  </id_info>
  <brief_title>Prophylactic Antibiotic Treatment for Hand Lacerations Involving Flexor and/or Extensor Tendon</brief_title>
  <official_title>Prophylactic Antibiotic Treatment for Hand Lacerations Involving Flexor and/or Extensor Tendon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators assume that simple hand lacerations involving flexors or extensors
      tendons, do not require prophylactic antibiotic treatment to prevent wound infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hand lacerations are divided to &quot;complicated&quot; which involves tendons, nerves, bones, and
      joints, and &quot;simple&quot; which involves only cutaneous and subcutaneous tissue.

      prophylactic antibiotic should not be given in a clean simple lacerations, and should be
      given when a bone is involve (open fracture). But there is not enough data, weather
      prophylactic antibiotic treatment should be given when only tendons are involved. The
      investigators will examine 2 groups of 30 patients each with clean hand lacerations
      involving tendons. One group will be treated with prophylactic antibiotic and the other wont
      be treated, randomly. The investigators assume that the rate of wound infection wont be
      different between the 2 groups.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>August 2013</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>rate of wound infections</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>signs of wound/tissue infection, levels of WBC, ESR, CRP</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hand Laceration</condition>
  <condition>Tendon Involved</condition>
  <condition>Clean Laceration</condition>
  <condition>No Bone Involved</condition>
  <arm_group>
    <arm_group_label>with antibiotic and without antibiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic-Cefamezin</intervention_name>
    <arm_group_label>with antibiotic and without antibiotic</arm_group_label>
    <other_name>Ceforal</other_name>
    <other_name>Keflex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hand laceration

          -  Tendon involeved

          -  Clean laceration

          -  No bone involved

        Exclusion Criteria:

          -  Pregnant

          -  Children

          -  Immunocompremised patients

          -  &quot;Dirty&quot; lacerations
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 12, 2013</lastchanged_date>
  <firstreceived_date>July 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lacerations</keyword>
  <keyword>Tendons</keyword>
  <keyword>Antobiotic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lacerations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
